scispace - formally typeset
Search or ask a question
Institution

Lincoln Hospital

HealthcareNew York, New York, United States
About: Lincoln Hospital is a healthcare organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Emergency department. The organization has 1033 authors who have published 929 publications receiving 14486 citations. The organization is also known as: Lincoln Medical and Mental Health Center & Lincoln Hospital.


Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the authors classified and described the different aspects of the treatment of tourniquet syndrome, and described a policy and procedure for the motorized removal of large bands by using a high revolutions per minute cutting device.
Abstract: A constricting band causing tourniquet syndrome is a common problem that can cause much frustration and pain for both the patient and practitioner. The following review classifies and describes the different aspects of the treatment of this condition. We also describe a policy and procedure for the motorized removal of large bands by using a high revolutions per minute cutting device.

24 citations

Journal Article
TL;DR: This report presents an unusual case of poisoning by the illegally imported rodenticide, “Tres Pasitos,” the main ingredient of which is aldicarb, a potent carbamate pesticide that causes fulminant cholinergic crisis.
Abstract: Rodenticides have historically been common agents in attempted suicides. As most rodenticides in the United States (U.S.) are superwarfarins, these ingestions are generally managed conservatively with close monitoring for coagulopathy, and if necessary, correction of any resulting coagulopathy. However, alternate forms of rodenticides are imported illegally into the U.S. and may be ingested either accidentally or in suicide attempts. We present an unusual case of poisoning by the illegally imported rodenticide, "Tres Pasitos." The main ingredient of this rat poison is aldicarb, a potent carbamate pesticide that causes fulminant cholinergic crisis. This case is relevant and timely because carbamates and organophosphates are still used as insecticides and emergency physicians (EP) working in rural areas may have to evaluate and manage patients with these poisonings. As international travel and immigration have increased, so has the possibility of encountering patients who have ingested toxic substances from other countries. In addition, there has been increased concern about the possibility of acts of terrorism using chemical substances that cause cholinergic toxidromes. EPs must be able to recognize and manage these poisonings. This report describes the mechanism of action, clinical manifestations, laboratory evaluation and management of this type of poisoning. The pertinent medical literature on poisoning with aldicarb and similar substances is reviewed. Language: en

23 citations

Journal ArticleDOI
TL;DR: Corticotropin-releasing hormone may be an important biomarker for predicting PTB in minority women, especially when combined with other predictors.
Abstract: Objective To determine the predictive capability of corticotropin-releasing hormone (CRH) as a biomarker of preterm birth (PTB) in minority women. Study design Venous blood samples were obtained at 22-24 weeks' gestation in a prospective, descriptive study of 707 minority women experiencing low-risk pregnancies. CRH was analyzed using a radioimmunoassay and methanol extraction protocol. Result CRH predicted PTB in both African American and Hispanic women. The odds ratio was 1.8 times greater for having a PTB if the CRH level was >24 pg/ml. The median CRH for African American women having a PTB was 46.6 pg/ml and for Hispanic women was 35.03 pg/ml. Using a receiver-operating characteristic curve, the threshold for CRH among the African American women was 30.6 pg/ml and among the Hispanic women was 27.4 pg/ml. Conclusion CRH may be an important biomarker for predicting PTB in minority women, especially when combined with other predictors.

23 citations

Journal ArticleDOI
26 Apr 2020-Cureus
TL;DR: A case of a middle-aged man with multiple co-morbidities, who was diagnosed with COVID-19 and acute appendicitis, who received intravenous antibiotics for seven days with a significant improvement in symptoms is reported.
Abstract: Appendectomy is the gold standard of treatment for acute appendicitis;however, recent evidence suggests conservative management with intravenous antibiotics may provide similar outcomes and can be used as an alternative in selected patients Performing appendectomy in acute appendicitis patients with 2019 novel Coronavirus Disease (COVID-19) is challenging, as it involves considerable operative risks for the patients and risks for health care professionals (HCPs) exposed to COVID-19 Medical management eliminates the morbidity and mortality associated with surgery but involves significant risks of treatment failures that, in turn, may lead to perforation, peritonitis, and death We are reporting a case of a middle-aged man with multiple co-morbidities, who was diagnosed with COVID-19 and acute appendicitis Our patient received intravenous antibiotics for seven days with a significant improvement in symptoms Our case report illustrates the implementation of successful conservative treatment for acute appendicitis in COVID-19 patients

23 citations

Journal ArticleDOI
TL;DR: DDAVP was associated with a lower incidence of hematoma expansion in patients with mild TBI who were prescribed pre-injury antiplatelet medications, which justifies a randomized controlled trial to further evaluate the role of DDAVP for this indication.
Abstract: Desmopressin (DDAVP) has been suggested for antiplatelet medication reversal in patients with traumatic brain injury (TBI) but there are limited data describing its effect on clinical outcomes. The purpose of this study was to evaluate the effect of DDAVP on hematoma expansion and thrombosis in patients with TBI who were prescribed pre-injury antiplatelet medications. Consecutive adult patients who were admitted to our level I trauma center and prescribed pre-injury antiplatelet medications between July, 2012, and May, 2018, were retrospectively identified. Patients were excluded if their hospital length of stay was 81 mg), ADP-receptor inhibitors, oral anticoagulants, prothrombin complex concentrates or platelets in a multivariate analysis, the association between DDAVP and hematoma expansion remained significant (adjusted OR 0.259 [95% CI 0.103–0.646], p = 0.004). Thrombotic events were similar between the two groups (DDAVP, 2.5%, no DDAVP, 4.5%; p = 0.613). DDAVP was associated with a lower incidence of hematoma expansion in patients with mild TBI who were prescribed pre-injury antiplatelet medications. These results justify a randomized controlled trial to further evaluate the role of DDAVP for this indication.

23 citations


Authors

Showing all 1035 results

Network Information
Related Institutions (5)
Henry Ford Hospital
12.4K papers, 465.3K citations

85% related

Boston Medical Center
9.9K papers, 441.6K citations

85% related

Mount Sinai St. Luke's and Mount Sinai Roosevelt
10.9K papers, 448.5K citations

84% related

Kaiser Permanente
24.3K papers, 1.2M citations

84% related

NewYork–Presbyterian Hospital
25.3K papers, 1M citations

83% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20231
20224
202178
202086
201984
201839